Michael W. Kalb - 10 May 2023 Form 3 Insider Report for IMPEL PHARMACEUTICALS INC

Role
CFO
Signature
/s/ Adrian Adams as attorney-in-fact
Issuer symbol
N/A
Transactions as of
10 May 2023
Net transactions value
$0
Form type
3
Filing time
12 May 2023, 16:22:23 UTC
Previous filing
24 Feb 2023
Next filing
03 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IMPL No securities beneficially held. 0 10 May 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24.1 - Power of Attorney